Korean J Pediatr.  2016 Apr;59(4):196-201. 10.3345/kjp.2016.59.4.196.

Concomitant use of corticosteroid and antimicrobials for liver abscesses in patients with chronic granulomatous disease

• Shin KS
• Lee MS

• KMID: 2163113
• DOI: http://doi.org/10.3345/kjp.2016.59.4.196

Abstract

Chronic granulomatous disease (CGD) is a rare inherited disorder caused by defective nicotinamide adenine dinucleotide phosphate oxidase enzyme and characterized by recurrent bacterial and fungal infections. Although liver abscess is a common manifestation of CGD, its management in CGD patients is not well-defined. In addition, the generalized guidelines for treating liver abscesses do not necessarily apply to CGD patients. Corticosteroids are commonly used to control granulomatous complications, such as inflammatory gastrointestinal and genitourinary lesions, in patients with CGD, Corticosteroids have also been used in combination with antimicrobials to treat refractory infections in patients with CGD. Because corticosteroids are capable of suppressing symptomatic inflammation, all potential infections must be adequately controlled prior to corticosteroid initiation. We report 3 typical CGD cases with liver abscesses refractory to conventional treatments that were successfully treated with the concomitant use of corticosteroid and antimicrobials. It remains unclear whether corticosteroid therapy is required for liver abscesses in CGD refractory to conventional treatments. However, based on our observations, use of corticosteroids in combination with optimal antimicrobials should be considered for refractory liver abscesses in CGD.

Keyword

Chronic granulomatous disease; Liver abscess; Corticosteroid

MeSH Terms

Adrenal Cortex Hormones
Granulomatous Disease, Chronic*
Humans
Inflammation
Liver Abscess*
Liver*
NADP
Oxidoreductases
Adrenal Cortex Hormones
NADP
Oxidoreductases